JP2005500982A5 - - Google Patents

Download PDF

Info

Publication number
JP2005500982A5
JP2005500982A5 JP2002560682A JP2002560682A JP2005500982A5 JP 2005500982 A5 JP2005500982 A5 JP 2005500982A5 JP 2002560682 A JP2002560682 A JP 2002560682A JP 2002560682 A JP2002560682 A JP 2002560682A JP 2005500982 A5 JP2005500982 A5 JP 2005500982A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002560682A
Other versions
JP2005500982A (ja
JP4236468B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/050423 external-priority patent/WO2002060491A2/en
Publication of JP2005500982A publication Critical patent/JP2005500982A/ja
Publication of JP2005500982A5 publication Critical patent/JP2005500982A5/ja
Application granted granted Critical
Publication of JP4236468B2 publication Critical patent/JP4236468B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002560682A 2000-10-24 2001-10-24 親水性チオエーテルおよび親水性６−ヒドロキシクロマンを用いた放射性医薬組成物の安定化 Expired - Fee Related JP4236468B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69536000A 2000-10-24 2000-10-24
US69549400A 2000-10-24 2000-10-24
US69499200A 2000-10-24 2000-10-24
PCT/US2001/050423 WO2002060491A2 (en) 2000-10-24 2001-10-24 Stabilization of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman

Publications (3)

Publication Number Publication Date
JP2005500982A JP2005500982A (ja) 2005-01-13
JP2005500982A5 true JP2005500982A5 (ja) 2005-12-22
JP4236468B2 JP4236468B2 (ja) 2009-03-11

Family

ID=27418608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002560682A Expired - Fee Related JP4236468B2 (ja) 2000-10-24 2001-10-24 親水性チオエーテルおよび親水性６−ヒドロキシクロマンを用いた放射性医薬組成物の安定化

Country Status (12)

Country Link
US (1) US20040058984A1 (ja)
EP (2) EP1808184A3 (ja)
JP (1) JP4236468B2 (ja)
AT (1) ATE355087T1 (ja)
AU (1) AU2002249863A1 (ja)
CA (1) CA2426587A1 (ja)
CY (1) CY1106622T1 (ja)
DE (1) DE60126994T2 (ja)
DK (1) DK1381397T3 (ja)
ES (1) ES2282326T3 (ja)
PT (1) PT1381397E (ja)
WO (1) WO2002060491A2 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
PL3456707T3 (pl) * 2007-11-06 2020-09-21 Ptc Therapeutics, Inc. Pochodne 4-(p-chinonylo)-2-hydroksybutanamidu do leczenia chorób mitochondrialnych
CN103599541A (zh) * 2008-09-10 2014-02-26 弗·哈夫曼-拉罗切有限公司 用于防止蛋白质氧化降解的组合物和方法
JP2014501702A (ja) * 2010-10-28 2014-01-23 ジーイー・ヘルスケア・リミテッド 放射性医薬品前駆体の安定化
EP2694095B1 (en) 2011-04-05 2018-03-07 Longevity Biotech, Inc. Compositions comprising glucagon analogs and methods of making and using the same
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
RU2668163C2 (ru) 2013-03-29 2018-09-26 Глитек, Инк. Полипептид, гликозилированный сиалилированной сахарной цепью
EP3525821A4 (en) 2016-10-17 2020-09-09 University of Maryland MULTI-SPECIFIC ANTIBODIES TARGETING THE HUMAN IMMUNODEFICIENCY VIRUS AND THEIR METHODS OF USE
EP3549946A4 (en) 2016-11-29 2020-10-21 Spiber Inc. COMPOSITION OF PROTEIN, ITS PRODUCTION PROCESS AND PROCESS FOR IMPROVING THERMAL STABILITY

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476772A (en) * 1966-10-20 1969-11-04 Eastman Kodak Co Chroman derivatives of 2,5-dimethyl-2,4-hexadiene
US3986980A (en) * 1974-04-29 1976-10-19 Hoffmann-La Roche Inc. Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid
JPS6094976A (ja) * 1983-10-28 1985-05-28 Sumitomo Chem Co Ltd クロマン誘導体およびその製造方法
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
US6030950A (en) * 1987-07-09 2000-02-29 Ohlenschlaeger; Gerhard Pharmaceutical therapeutic use of glutathione derivative
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
WO1993002652A2 (en) * 1991-08-01 1993-02-18 Hybritech Incorporated Modified haptens useful as imaging and therapeutic agents
JPH06228170A (ja) * 1993-02-04 1994-08-16 Noda Sangyo Kagaku Kenkyusho ホスファチジルクロマノール誘導体、その製造方法、抗酸化剤及び乳化剤
JP3051591B2 (ja) * 1993-03-05 2000-06-12 日本メジフィジックス株式会社 タリウム−２０１の容器に対する付着防止剤
JP3839071B2 (ja) * 1993-12-07 2006-11-01 有限会社ケムフィズ クロマン誘導体
TW486499B (en) * 1997-10-02 2002-05-11 Yoshitomi Fine Chemicals Ltd A stabilizer composition containing 6-hydroxy compound for organic polymer material and an organic polymer composition
EP0955355A3 (en) * 1998-04-28 2000-08-02 Ciba SC Holding AG Antioxidants for the stabilization of formulations comprising surfactants
US6171578B1 (en) * 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi

Similar Documents

Publication Publication Date Title
BE2022C531I2 (ja)
BE2022C502I2 (ja)
BE2017C056I2 (ja)
BE2017C051I2 (ja)
BE2017C032I2 (ja)
BE2016C051I2 (ja)
BE2015C046I2 (ja)
BE2014C052I2 (ja)
BE2014C036I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2014C006I2 (ja)
BE2017C050I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
BRPI0209186B1 (ja)
BE2014C008I2 (ja)
CH1379220H1 (ja)
BRPI0204884B1 (ja)
BE2017C059I2 (ja)
BRPI0101486B8 (ja)
BE2012C051I2 (ja)
BRPI0210463A2 (ja)
JP2005500982A5 (ja)
AU2000280389A8 (ja)